Early Kidney Injury Biomarkers in Gynecologic Laparoscopic Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
Pneumoperitoneum and Trendelenburg Positioning: Standard intraoperative carbon dioxide pneumoperitoneum combined with either 30° or 45° Trendelenburg positioning during laparoscopic surgery
Study summary
This prospective observational study aims to evaluate early subclinical acute kidney injury associated with pneumoperitoneum and Trendelenburg positioning during gynecological laparoscopic surgery. Urinary neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) levels will be measured and normalized to urinary creatinine. Biomarker changes will be compared between patients undergoing surgery in 30° and 45° Trendelenburg positions. The study seeks to determine whether these biomarkers can detect early renal injury before clinically significant changes in serum creatinine occur.
Eligibility
Primary outcome measure(s)
- Perioperative Changes in Urinary Renal Tubular Injury Biomarkers — Baseline (after induction of anesthesia and urinary catheterization) and postoperative 6 hours.
Perioperative changes in urinary neutrophil gelatinase-associated lipocalin (NGAL)/creatinine and kidney injury molecule-1 (KIM-1)/creatinine ratios from baseline (after induction of anesthesia and urinary catheterization) to the sixth postoperative hour. Biomarker changes will be compared between participants undergoing surgery in approximately 30° and 45° Trendelenburg positions
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Medipol Mega University Hospital | Istanbul | Istanbul |
More Medipol University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07704242 on ClinicalTrials.gov ↗ ← All trials in Turkey